Survival Benefit from the Initiation of Antiretroviral Therapy is Compromised by Baseline CD4 + T Cell Counts Below 200 Cells/mm and not Plasma HIV-1 RNA Levels

Español (soon!) - September 7, 2008

CMEonHIV.com is dedicated to providing online CME presentations (slides with voiceover) on HIV/AIDS for healthcare professionals given by local and international experts to keep you up-to-date on the ongoing developments in the field.

Conference

"Survival Benefit from the Initiation of Antiretroviral Therapy is Compromised by Baseline CD4 + T Cell Counts Below 200 Cells/mm and not Plasma HIV-1 RNA Levels"
Dr. Robert Hogg (biography)
English - 2001-06-01 - 17 minutes

(15 slides)

Login

	Please log in and get access to thousands of resources about HIV disease and its treatment.
	Already a member?
	Username :
	Password :

	Lost your password?

Search our database

Find the information that you are looking for in over +3000 resources.

ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

CMEonHIV is owned by E-MedHosting.com.

Copyright @ 2002-2008 E-MedHosting.com. All rights reserved. Disclaimer | Sponsor Disclaimer

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR
BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.